| The knowledge-gradient algorithm for sequencing experiments in drug discovery DM Negoescu, PI Frazier, WB Powell INFORMS Journal on Computing 23 (3), 346-363, 2011 | 190 | 2011 |
| Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis DE Winetsky, DM Negoescu, EH DeMarchis, O Almukhamedova, ... PLoS medicine 9 (11), e1001348, 2012 | 86 | 2012 |
| Dynamic learning of patient response types: An application to treating chronic diseases DM Negoescu, K Bimpikis, ML Brandeau, DA Iancu Management science 64 (8), 3469-3488, 2018 | 69 | 2018 |
| Proactive vs reactive therapeutic drug monitoring of infliximab in Crohn˘s disease: a cost-effectiveness analysis in a simulated cohort DM Negoescu, EA Enns, B Swanhorst, B Baumgartner, JP Campbell, ... Inflammatory bowel diseases 26 (1), 103-111, 2020 | 45 | 2020 |
| Design of incentive programs for optimal medication adherence in the presence of observable consumption S Suen, D Negoescu, J Goh Operations Research 70 (3), 1691-1716, 2022 | 14 | 2022 |
| Public/Private Partnerships in transit: Case studies and analysis M Blodgett, A Khani, D Negoescu, S Benjaafar Minnesota Council on Transportation Access, 2017 | 10 | 2017 |
| Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal? DM Negoescu, DK Owens, ML Brandeau, E Bendavid Clinical infectious diseases 55 (10), 1392-1399, 2012 | 9 | 2012 |
| Design of incentive programs for optimal medication adherence S Suen, D Negoescu, J Goh Available at SSRN 3308510, 2018 | 7 | 2018 |
| Differentiated human immunodeficiency virus RNA monitoring in resource-limited settings: an economic analysis DM Negoescu, Z Zhang, HC Bucher, E Bendavid, Swiss HIV Cohort Study Clinical infectious diseases 64 (12), 1724-1730, 2017 | 7* | 2017 |
| Crystalcandle: A user-facing model explainer for narrative explanations J Yang, D Negoescu, P Ahammad arXiv preprint arXiv:2105.12941, 2021 | 3 | 2021 |
| When and what to test for: A cost-effectiveness analysis of febrile illness test-and-treat strategies in the era of responsible antibiotic use AZ Zhang, D Negoescu, C Munoz-Zanzi Plos one 15 (1), e0227409, 2020 | 3 | 2020 |
| Optimal learning for drug discovery in ewing˘s sarchoma D Negoescu, P Frazier To appear, 2011 | 3 | 2011 |
| Does mothers˘ and caregivers' access to information on their child˘s vaccination card impact the timing of their child˘s measles vaccination in Uganda? BC Griffith, SE Cusick, KM Searle, DM Negoescu, NE Basta, C Banura BMC public health 22 (1), 834, 2022 | 2 | 2022 |
| Intellige: A user-facing model explainer for narrative explanations J Yang, D Negoescu, P Ahammad arXiv preprint arXiv:2105.12941, 2021 | 2 | 2021 |
| Managing Uncertainty in Sequential Medical Decision Making DM Negoescu stanford university, 2014 | 1 | 2014 |
| Epsilon*: Privacy Metric for Machine Learning Models DM Negoescu, H Gonzalez, SEA Orjany, J Yang, Y Lut, R Tandra, ... arXiv preprint arXiv:2307.11280, 2023 | | 2023 |
| Sales Channel Optimization via Simulations Based on Observational Data with Delayed Rewards: A Case Study at LinkedIn DM Negoescu, P Khosravi, S Zhao, N Chen, P Ahammad, H Gonzalez arXiv preprint arXiv:2209.07749, 2022 | | 2022 |
| Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn˘s Disease: Mathematical Modeling and Cost-Effectiveness Analysis D Negoescu, EA Enns, B Swanhorst, B Baumgartner, B Vaughn 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Cost-Effectiveness Analysis of Clinical Management Strategies for Undifferentiated Febrile Illness in the Era of Responsible Antibiotic Use Z Zhang, D Negoescu, C Munoz-Zanzi 40th Annual Meeting of the Society for Medical Decision Making, 2018 | | 2018 |
| Optimal Learning for Drug Discovery in Ewing˘s Sarcoma DMNPI Frazier | | 2009 |
